Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - B. Riley lowered their Q1 2025 earnings per share estimates for Aspen Aerogels in a research report issued on Wednesday, February 19th. B. Riley analyst R. Pfingst now forecasts that the construction company will post earnings per share of ($0.08) for the quarter, down from their prior estimate of $0.09. B. Riley has a "Buy" rating and a $22.00 price objective on the stock. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.17 per share. B. Riley also issued estimates for Aspen Aerogels' Q2 2025 earnings at $0.02 EPS and FY2025 earnings at $0.22 EPS.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%.
ASPN has been the subject of several other reports. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Barclays lowered their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a research report on Wednesday, February 19th. Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Craig Hallum reduced their target price on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a research note on Friday, February 14th. Finally, Roth Mkm dropped their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $22.44.
Read Our Latest Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 3.5 %
Shares of ASPN traded down $0.28 on Friday, reaching $7.50. The company's stock had a trading volume of 2,443,109 shares, compared to its average volume of 2,156,701. The stock has a market capitalization of $614.96 million, a PE ratio of 46.85 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a twelve month low of $7.45 and a twelve month high of $33.15. The firm has a fifty day moving average of $11.55 and a 200-day moving average of $17.96.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ASPN. Vanguard Group Inc. raised its holdings in shares of Aspen Aerogels by 5.5% in the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock worth $51,800,000 after purchasing an additional 226,251 shares during the period. FMR LLC raised its stake in shares of Aspen Aerogels by 23.6% in the third quarter. FMR LLC now owns 4,050,896 shares of the construction company's stock valued at $112,169,000 after buying an additional 773,647 shares during the period. Oaktop Capital Management II L.P. lifted its position in shares of Aspen Aerogels by 5.6% during the 4th quarter. Oaktop Capital Management II L.P. now owns 3,740,525 shares of the construction company's stock valued at $44,437,000 after buying an additional 200,000 shares during the last quarter. Needham Investment Management LLC grew its stake in shares of Aspen Aerogels by 5.2% during the 4th quarter. Needham Investment Management LLC now owns 2,389,700 shares of the construction company's stock worth $28,390,000 after acquiring an additional 117,500 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Aspen Aerogels by 25.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock worth $23,983,000 after acquiring an additional 409,862 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Recommended Stories
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
